Cited by 99Antifungal resistance and susceptibilityAntibiotic Use and ResistanceOcular Infections and Treatments

The current treatment landscape: Candidiasis

Bassetti, Matteo, Peghin, Maddalena, Timsit, Jean-Francois·2016·Journal of Antimicrobial Chemotherapy

Abstract

The epidemiology of Candida species infection has changed over recent decades, influenced by local hospital-related factors, patient predisposing conditions and type of antifungal agents administered. A shift from Candida albicans as the predominant pathogen towards an increasing prevalence of the species Candida glabrata and Candida parapsilosis amongst critically ill patients has been documented. Changes in Candida species distribution may impact treatment recommendations due to differences in susceptibility to antifungal agents among species. Previous exposure to antifungal agents has likely contributed to this shift in species distribution. Another evolving epidemiological factor to consider is the global increase in antifungal resistance to certain antifungal drug types, which has been contributed to by the inappropriate use of these agents. Proposed management strategies to optimize treatment of patients with Candida infection include starting prompt 'early' antifungal therapy, early cessation of inappropriate therapy, using an adequate dose and duration of therapy and de-escalating treatment whenever possible. The implementation of institutional antifungal stewardship programmes has the potential to promote appropriate utilization of antifungal agents and to significantly improve the care of patients with Candida infection. However, a cultural change among healthcare providers and authorities is currently needed to improve antifungal use worldwide.

Integrity signals

Registry

Crossref · 10.1093/jac/dkw392

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Candida is responsible for the most common invasive fungal disease in developed countries, candidiasis.

    “Species belonging to the genera Candida, Aspergillus, and Cryptococcus are the most prevalent cause of invasive infections, with Candida being responsible for the most common invasive fungal disease in developed countries—candidiasis [3].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bassetti, M., Peghin, M., & Timsit, J.-F.
Affiliations
University of Udine (IT)
Corresponding author
Bassetti, Matteo
Venue
Journal of Antimicrobial Chemotherapy
Published
2016-10-20
Volume
71
Issue
suppl 2
Pages
ii13-ii22
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2537521331
Cited by
99
References
65
Citations by year
2026: 5 · 2025: 6 · 2024: 10 · 2023: 13 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 13 · 2018: 13 · 2017: 7 · 2016: 1
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (University of Udine) (submittedVersion)
  • IrInSubria (University of Insubria) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
candidiasis, Candida species distribution, Candida albicans, Candida glabrata, Candida parapsilosis, antifungal resistance, antifungal stewardship, treatment de-escalation, critically ill patients, fungal epidemiology
MeSH terms
Antifungal Agents, Candida albicans, Humans, Intensive Care Units, Microbial Sensitivity Tests, Fungemia, Antibiotic Prophylaxis, Candida glabrata, Secondary Prevention, Inappropriate Prescribing, Candidiasis, Invasive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review